101 related articles for article (PubMed ID: 28753889)
21. A genetic polymorphism affects the risk and prognosis of renal cell carcinoma: association with follistatin-like protein 1 expression.
Liu Y; Han X; Yu Y; Ding Y; Ni C; Liu W; Hou X; Li Z; Hou J; Shen D; Yin J; Zhang H; Thompson TC; Tan X; Cao G
Sci Rep; 2016 May; 6():26689. PubMed ID: 27225192
[TBL] [Abstract][Full Text] [Related]
22. Association of Single Nucleotide Polymorphisms in STAT3 with Hand-Foot Skin Reactions in Patients with Metastatic Renal Cell Carcinoma Treated with Multiple Tyrosine Kinase Inhibitors: A Retrospective Analysis in Japanese Patients.
Yamamoto K; Shinomiya K; Ioroi T; Hirata S; Harada K; Suno M; Nishioka T; Kume M; Makimoto H; Nakagawa T; Hirano T; Bito T; Nishigori C; Miyake H; Fujisawa M; Hirai M
Target Oncol; 2016 Feb; 11(1):93-9. PubMed ID: 26300443
[TBL] [Abstract][Full Text] [Related]
23. Uromodulin associates with cardiorenal function in patients with hypertension and cardiovascular disease.
Algharably EAH; Bolbrinker J; Lezius S; Reibis R; Wegscheider K; Völler H; Kreutz R
J Hypertens; 2017 Oct; 35(10):2053-2058. PubMed ID: 28598953
[TBL] [Abstract][Full Text] [Related]
24. HTERT promoter methylation and single nucleotide polymorphism (-245 T>C) affect renal cell carcinoma behavior in Serbian population.
Trifunovic J; Basta Jovanovic G; Nikolic N; Carkic J; Marjanovic A; Brankovic M; Radojevic Skodric S; Prvanovic M; Jovanovic A; Dzamic Z; Milasin J
J BUON; 2018; 23(6):1887-1892. PubMed ID: 30610818
[TBL] [Abstract][Full Text] [Related]
25. Microvascular and lymphovascular tumour invasion are associated with poor prognosis and metastatic spread in renal cell carcinoma: a validation study in clinical practice.
Bedke J; Heide J; Ribback S; Rausch S; de Martino M; Scharpf M; Haitel A; Zimmermann U; Pechoel M; Alkhayyat H; Shariat SF; Dombrowski F; Stenzl A; Burchardt M; Klatte T; Kroeger N
BJU Int; 2018 Jan; 121(1):84-92. PubMed ID: 28803448
[TBL] [Abstract][Full Text] [Related]
26. Type of uromodulin mutation and allelic status influence onset and severity of uromodulin-associated kidney disease in mice.
Kemter E; Prueckl P; Sklenak S; Rathkolb B; Habermann FA; Hans W; Gailus-Durner V; Fuchs H; Hrabě de Angelis M; Wolf E; Aigner B; Wanke R
Hum Mol Genet; 2013 Oct; 22(20):4148-63. PubMed ID: 23748428
[TBL] [Abstract][Full Text] [Related]
27. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter is associated with conventional renal cell carcinoma.
Hirata H; Naito K; Yoshihiro S; Matsuyama H; Suehiro Y; Hinoda Y
Int J Cancer; 2003 Sep; 106(3):372-4. PubMed ID: 12845675
[TBL] [Abstract][Full Text] [Related]
28. Impact of interleukin-18 polymorphisms-607 and -137 on clinical characteristics of renal cell carcinoma patients.
Sáenz-López P; Carretero R; Vazquez F; Martin J; Sánchez E; Tallada M; Garrido F; Cózar JM; Ruiz-Cabello F
Hum Immunol; 2010 Mar; 71(3):309-13. PubMed ID: 19961892
[TBL] [Abstract][Full Text] [Related]
29. The bcl2 -938CC genotype has poor prognosis and lower survival in renal cancer.
Hirata H; Hinoda Y; Nakajima K; Kikuno N; Suehiro Y; Tabatabai ZL; Ishii N; Dahiya R
J Urol; 2009 Aug; 182(2):721-7. PubMed ID: 19539330
[TBL] [Abstract][Full Text] [Related]
30. High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profile.
Baldewijns MM; Thijssen VL; Van den Eynden GG; Van Laere SJ; Bluekens AM; Roskams T; van Poppel H; De Bruïne AP; Griffioen AW; Vermeulen PB
Br J Cancer; 2007 Jun; 96(12):1888-95. PubMed ID: 17505508
[TBL] [Abstract][Full Text] [Related]
31. Uromodulin and chronic kidney disease.
Lhotta K
Kidney Blood Press Res; 2010; 33(5):393-8. PubMed ID: 20948228
[TBL] [Abstract][Full Text] [Related]
32. Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma.
Bianconi M; Faloppi L; Loretelli C; Zizzi A; Giampieri R; Bittoni A; Andrikou K; Del Prete M; Burattini L; Montironi R; Scartozzi M; Cascinu S
Oncotarget; 2016 Jun; 7(25):37599-37607. PubMed ID: 27175586
[TBL] [Abstract][Full Text] [Related]
33. ASSOCIATION OF GENETIC POLYMORPHISM AND EXPRESSION OF UMOD GENE AND CHRONIC KIDNEY DISEASE.
Hasan FT; Mohey MA
Wiad Lek; 2021; 74(9 cz 2):2297-2300. PubMed ID: 34824175
[TBL] [Abstract][Full Text] [Related]
34. The Uromodulin Gene Locus Shows Evidence of Pathogen Adaptation through Human Evolution.
Ghirotto S; Tassi F; Barbujani G; Pattini L; Hayward C; Vollenweider P; Bochud M; Rampoldi L; Devuyst O
J Am Soc Nephrol; 2016 Oct; 27(10):2983-2996. PubMed ID: 26966016
[TBL] [Abstract][Full Text] [Related]
35. Role of the STK15 Phe31Ile polymorphism in renal cell carcinoma.
Hammerschmied CG; Stoehr R; Walter B; Wieland WF; Hartmann A; Blaszyk H; Denzinger S
Oncol Rep; 2007 Jan; 17(1):3-7. PubMed ID: 17143471
[TBL] [Abstract][Full Text] [Related]
36. Common variants in UMOD associate with urinary uromodulin levels: a meta-analysis.
Olden M; Corre T; Hayward C; Toniolo D; Ulivi S; Gasparini P; Pistis G; Hwang SJ; Bergmann S; Campbell H; Cocca M; Gandin I; Girotto G; Glaudemans B; Hastie ND; Loffing J; Polasek O; Rampoldi L; Rudan I; Sala C; Traglia M; Vollenweider P; Vuckovic D; Youhanna S; Weber J; Wright AF; Kutalik Z; Bochud M; Fox CS; Devuyst O
J Am Soc Nephrol; 2014 Aug; 25(8):1869-82. PubMed ID: 24578125
[TBL] [Abstract][Full Text] [Related]
37. Development and characterization of a pseudo multiple reaction monitoring method for the quantification of human uromodulin in urine.
Hammond TG; Moes S; Youhanna S; Jennings P; Devuyst O; Odermatt A; Jenö P
Bioanalysis; 2016 Jun; 8(12):1279-96. PubMed ID: 27187191
[TBL] [Abstract][Full Text] [Related]
38. Uromodulin gene variant is associated with type 2 diabetic nephropathy.
Ahluwalia TS; Lindholm E; Groop L; Melander O
J Hypertens; 2011 Sep; 29(9):1731-4. PubMed ID: 21738052
[TBL] [Abstract][Full Text] [Related]
39. Association between three VEGF polymorphisms and renal cell carcinoma susceptibility: a meta-analysis.
Hou Q; Li MY; Huang WT; Wei FF; Peng JP; Lou MW; Qiu JG
Oncotarget; 2017 Jul; 8(30):50061-50070. PubMed ID: 28562357
[TBL] [Abstract][Full Text] [Related]
40. Genome-wide association study of blood pressure extremes identifies variant near UMOD associated with hypertension.
Padmanabhan S; Melander O; Johnson T; Di Blasio AM; Lee WK; Gentilini D; Hastie CE; Menni C; Monti MC; Delles C; Laing S; Corso B; Navis G; Kwakernaak AJ; van der Harst P; Bochud M; Maillard M; Burnier M; Hedner T; Kjeldsen S; Wahlstrand B; Sjögren M; Fava C; Montagnana M; Danese E; Torffvit O; Hedblad B; Snieder H; Connell JM; Brown M; Samani NJ; Farrall M; Cesana G; Mancia G; Signorini S; Grassi G; Eyheramendy S; Wichmann HE; Laan M; Strachan DP; Sever P; Shields DC; Stanton A; Vollenweider P; Teumer A; Völzke H; Rettig R; Newton-Cheh C; Arora P; Zhang F; Soranzo N; Spector TD; Lucas G; Kathiresan S; Siscovick DS; Luan J; Loos RJ; Wareham NJ; Penninx BW; Nolte IM; McBride M; Miller WH; Nicklin SA; Baker AH; Graham D; McDonald RA; Pell JP; Sattar N; Welsh P; ; Munroe P; Caulfield MJ; Zanchetti A; Dominiczak AF
PLoS Genet; 2010 Oct; 6(10):e1001177. PubMed ID: 21082022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
